Enanta PharmaceuticalsENTA
那斯達克 · USD
13.16
-0.34
(-2.52%)
盤中 09/10 02:23 (UTC+8)
09/10 02:23 (UTC+8)
Enanta PharmaceuticalsENTA
13.16
-0.34
(-2.52%)
財務數據
損益表
- 0.17
- 0.18
- 0.15
- 0.17
- 0.15
- 0.18
- 0.15
- 0.19
- 0.17
- 0.14
- -5.27
- 5.38
- -18.72
- 16.10
- -11.99
- 22.70
- -17.41
- 23.07
- -7.82
- -16.32
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 14,359 | 17,159 | 18,615 | 15,125 | 18,314 | 14,926 | 16,959 | 14,607 | 17,971 | 17,054 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 14,359 | 17,159 | 18,615 | 15,125 | 18,314 | 14,926 | 16,959 | 14,607 | 17,971 | 17,054 |
營業費用 | 31,595 | 29,011 | 29,868 | 33,511 | 37,207 | - | - | - | - | - |
研發費用 | 22,126 | 19,443 | 20,859 | 23,809 | 27,210 | 28,065 | 27,656 | 30,778 | 28,742 | 35,585 |
推銷及管理費用 | 9,469 | 9,568 | 9,009 | 9,702 | 9,997 | 11,388 | 12,846 | 13,683 | 13,414 | 14,235 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -17,236 | -11,852 | -11,253 | -18,386 | -18,893 | -24,527 | -23,543 | -29,854 | -24,185 | -32,766 |
其他收入及費用 | 1,901 | 2,084 | 2,422 | 2,105 | 2,285 | 2,292 | 2,799 | 3,249 | 3,487 | 3,809 |
利息費用 | 4,130 | 3,316 | 3,083 | 2,387 | 1,618 | 1,714 | 1,962 | 2,581 | 2,355 | 2,563 |
稅前純益 | -19,465 | -13,084 | -11,914 | -18,668 | -18,226 | -23,949 | -22,706 | -29,186 | -23,053 | -31,520 |
所得稅 | 36 | 7 | 24 | 32 | 29 | -1,305 | -416 | -363 | -395 | -363 |
稅後純益 | -19,501 | -13,091 | -11,938 | -18,700 | -18,255 | -22,644 | -22,290 | -28,823 | -22,658 | -31,157 |
基本每股稅後盈餘(元) | -0.67 | -0.45 | -0.42 | -0.87 | -0.85 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 |
稀釋每股稅後盈餘(元) | -0.67 | -0.45 | -0.42 | -0.88 | -0.85 | -1.06 | -1.05 | -1.36 | -1.06 | -1.48 |
基本平均股數(千股) | 29090.00 | 29040.00 | 28748.00 | 21380.00 | 21377.00 | 21355.00 | 21238.00 | 21190.00 | 21180.00 | 21167.00 |
稀釋平均股數(千股) | 29090.00 | 29040.00 | 28748.00 | 21380.00 | 21377.00 | 21355.00 | 21238.00 | 21190.00 | 21180.00 | 21167.00 |
還原基本每股稅後盈餘(元) | -0.67 | -0.45 | -0.42 | -0.87 | -0.85 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 |
還原稀釋每股稅後盈餘(元) | -0.67 | -0.45 | -0.42 | -0.88 | -0.85 | -1.06 | -1.05 | -1.36 | -1.06 | -1.48 |
還原基本平均股數(千股) | 29,090 | 29,040 | 28,748 | 21,380 | 21,377 | 21,355 | 21,238 | 21,190 | 21,180 | 21,167 |
還原稀釋平均股數(千股) | 29,090 | 29,040 | 28,748 | 21,380 | 21,377 | 21,355 | 21,238 | 21,190 | 21,180 | 21,167 |
EBITDA(千元) | -14,142 | -8,257 | -7,581 | -15,955 | -15,385 | -20,216 | -19,223 | -27,328 | -20,339 | -28,311 |